Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Editas Medicine, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
215 institutional managers report a position in Editas Medicine, Inc. worth $391.4M between them, filed on form 13F for the quarter ending 2026-06-30. 21 of them hold 80% of it, the largest being TCG Crossover Management, LLC at 9.20%.
190 more managers in the register
21 managers hold 80% of the $391.4M institutional base. The other 194 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via TCG Crossover Management, LLC, ADAR1 Capital Management, LLC, RA Capital Management, LLC +4 more · 9.20% of EDIT, 14.13% of ZLAB
via TCG Crossover Management, LLC, RA Capital Management, LLC, Commodore Capital LP +4 more · 9.20% of EDIT, 11.19% of IPSC
via RA Capital Management, LLC, Commodore Capital LP, ADAR1 Capital Management, LLC +4 more · 7.36% of EDIT, 38.51% of PEPG
via TCG Crossover Management, LLC, Commodore Capital LP, ADAR1 Capital Management, LLC +3 more · 9.20% of EDIT, 15.32% of IFRX
via RA Capital Management, LLC, Commodore Capital LP, TCG Crossover Management, LLC +4 more · 7.36% of EDIT, 7.42% of LBRX
via TCG Crossover Management, LLC, RA Capital Management, LLC, Paradigm Biocapital Advisors LP +5 more · 9.20% of EDIT, 11.68% of VOR
Managers holding a meaningful stake in EDIT also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
EDIT (Editas Medicine, Inc.) has 5 disclosed suppliers and 8 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.